Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 5.07x is 56% below its estimated 5-year average of 11.46x, near the low end of its estimated 5-year range (1.04x–69.90x).
As of 2026-10-06T21:13:55.108Z. 24.95% below its estimated 12-month average of 6.76x.
Calculation as of: 2026-10-06T21:13:55.108Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8cbf2c4bedb1eff0bddc45c0acac52f2eee77af7ab0e1536e55dbd1c791948ce
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
5.07x
EV/SALES RATIO AVG TTM
6.76x
EV/SALES RATIO AVG 3Y
11.97x
EV/SALES RATIO AVG 5Y
11.46x
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-24.95%
CURRENT VS 3Y AVG
-57.66%
CURRENT VS 5Y AVG
-55.76%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.38x
median of 549 covered companies
CURRENT VS SECTOR MEDIAN
+15.75%
vs the sector median at left
Tarsus Pharmaceuticals, Inc.
Market Cap
$3.19B
EV/Sales Ratio
5.07x
TTM Avg
6.76x
3Y Avg
11.97x
5Y Avg
11.46x
Market Cap
$3.12B
EV/Sales Ratio
N/A
TTM Avg
1.20x
3Y Avg
895.62x
5Y Avg
895.62x
Market Cap
$3.06B
EV/Sales Ratio
800.75x
TTM Avg
1123.66x
3Y Avg
904.58x
5Y Avg
368.85x
Market Cap
$3.38B
EV/Sales Ratio
2.70x
TTM Avg
3.65x
3Y Avg
3.66x
5Y Avg
4.78x
Market Cap
$2.99B
EV/Sales Ratio
6.62x
TTM Avg
9.31x
3Y Avg
10.36x
5Y Avg
140.89x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | $3.19B | 5.07x | 6.76x | 11.97x | 11.46x |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.12B | N/A | 1.20x | 895.62x | 895.62x |
| CareDx, Inc (CDNA)vs › | $3.30B | 6.43x | 3.21x | 2.88x | 3.18x |
| Viking Therapeutics, Inc. (VKTX)vs › | $3.31B | N/A | N/A | N/A | N/A |
| Denali Therapeutics Inc. (DNLI)vs › | $3.06B | 800.75x | 1123.66x | 904.58x | 368.85x |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.03B | N/A | N/A | N/A | N/A |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.36B | N/A | N/A | N/A | N/A |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 2.70x | 3.65x | 3.66x | 4.78x |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $2.99B | 6.62x | 9.31x | 10.36x | 140.89x |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | 2825.60x | 5544.59x | 5544.59x | 2117.19x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 5.14x |
| 2026-10-02 | 5.03x |
| 2026-10-01 | 5.21x |
| 2026-09-30 | 5.43x |
| 2026-09-29 | 5.30x |
| 2026-09-28 | 5.31x |
| 2026-09-25 | 5.23x |
| 2026-09-24 | 5.25x |
| 2026-09-23 | 5.13x |
| 2026-09-22 | 5.33x |
| 2026-09-21 | 5.35x |
| 2026-09-18 | 5.40x |
| 2026-09-17 | 5.46x |
| 2026-09-16 | 5.37x |
| 2026-09-15 | 5.41x |
| 2026-09-14 | 5.53x |
| 2026-09-11 | 5.48x |
| 2026-09-10 | 5.61x |
| 2026-09-09 | 5.73x |
| 2026-09-08 | 6.05x |
| 2026-09-04 | 6.31x |
| 2026-09-03 | 5.76x |
| 2026-09-02 | 5.73x |
| 2026-09-01 | 5.11x |
| 2026-08-31 | 5.12x |
| 2026-08-28 | 4.94x |
| 2026-08-27 | 4.96x |
| 2026-08-26 | 4.87x |
| 2026-08-25 | 4.92x |
| 2026-08-24 | 5.02x |
| 2026-08-21 | 5.01x |
| 2026-08-20 | 4.93x |
| 2026-08-19 | 5.06x |
| 2026-08-18 | 4.89x |
| 2026-08-17 | 4.86x |
| 2026-08-14 | 4.76x |
| 2026-08-13 | 4.74x |
| 2026-08-12 | 4.82x |
| 2026-08-11 | 4.78x |
| 2026-08-10 | 4.66x |
| 2026-08-07 | 4.45x |
| 2026-08-06 | 5.22x |
| 2026-08-05 | 4.90x |
| 2026-08-04 | 4.88x |
| 2026-08-03 | 4.90x |
| 2026-07-31 | 4.71x |
| 2026-07-30 | 4.75x |
| 2026-07-29 | 4.67x |
| 2026-07-28 | 4.71x |
| 2026-07-27 | 4.80x |
| 2026-07-24 | 4.68x |
| 2026-07-23 | 4.68x |
| 2026-07-22 | 4.60x |
| 2026-07-21 | 4.57x |
| 2026-07-20 | 4.49x |
| 2026-07-17 | 4.78x |
| 2026-07-16 | 4.61x |
| 2026-07-15 | 4.59x |
| 2026-07-14 | 4.48x |
| 2026-07-13 | 4.74x |
| 2026-07-10 | 4.64x |
| 2026-07-09 | 5.12x |
| 2026-07-08 | 5.41x |
| 2026-07-07 | 5.64x |
| 2026-07-06 | 5.36x |
| 2026-07-02 | 5.23x |
| 2026-07-01 | 4.86x |
| 2026-06-30 | 5.03x |
| 2026-06-29 | 4.89x |
| 2026-06-26 | 5.03x |
| 2026-06-25 | 5.14x |
| 2026-06-24 | 5.36x |
| 2026-06-23 | 5.29x |
| 2026-06-22 | 5.08x |
| 2026-06-18 | 5.05x |
| 2026-06-17 | 5.00x |
| 2026-06-16 | 4.86x |
| 2026-06-15 | 4.94x |
| 2026-06-12 | 4.95x |
| 2026-06-11 | 5.00x |
| 2026-06-10 | 4.89x |
| 2026-06-09 | 4.92x |
| 2026-06-08 | 4.76x |
| 2026-06-05 | 4.73x |
| 2026-06-04 | 4.82x |
| 2026-06-03 | 4.69x |
| 2026-06-02 | 4.58x |
| 2026-06-01 | 4.71x |
| 2026-05-29 | 4.74x |
| 2026-05-28 | 4.75x |
| 2026-05-27 | 4.80x |
| 2026-05-26 | 4.88x |
| 2026-05-22 | 4.97x |
| 2026-05-21 | 5.07x |
| 2026-05-20 | 5.18x |
| 2026-05-19 | 4.90x |
| 2026-05-18 | 5.02x |
| 2026-05-15 | 4.99x |
| 2026-05-14 | 5.21x |
| 2026-05-13 | 5.17x |
| 2026-05-12 | 4.78x |
| 2026-05-11 | 4.76x |
| 2026-05-08 | 4.89x |
| 2026-05-07 | 5.11x |
| 2026-05-06 | 5.94x |
| 2026-05-05 | 5.97x |
| 2026-05-04 | 5.92x |
| 2026-05-01 | 5.83x |
| 2026-04-30 | 5.83x |
| 2026-04-29 | 5.55x |
| 2026-04-28 | 5.69x |
| 2026-04-27 | 5.58x |
| 2026-04-24 | 5.63x |
| 2026-04-23 | 5.58x |
| 2026-04-22 | 5.82x |
| 2026-04-21 | 5.92x |
| 2026-04-20 | 6.05x |
| 2026-04-17 | 6.17x |
| 2026-04-16 | 6.22x |
| 2026-04-15 | 6.61x |
| 2026-04-14 | 6.80x |
| 2026-04-13 | 6.69x |
| 2026-04-10 | 6.68x |
| 2026-04-09 | 6.67x |
| 2026-04-08 | 6.62x |
| 2026-04-07 | 6.32x |
| 2026-04-06 | 6.45x |
| 2026-04-02 | 6.45x |
| 2026-04-01 | 6.46x |
| 2026-03-31 | 6.45x |
| 2026-03-30 | 6.14x |
| 2026-03-27 | 6.08x |
| 2026-03-26 | 6.17x |
| 2026-03-25 | 6.15x |
| 2026-03-24 | 5.79x |
| 2026-03-23 | 5.88x |
| 2026-03-20 | 5.92x |
| 2026-03-19 | 6.13x |
| 2026-03-18 | 6.27x |
| 2026-03-17 | 6.42x |
| 2026-03-16 | 6.33x |
| 2026-03-13 | 6.24x |
| 2026-03-12 | 6.26x |
| 2026-03-11 | 6.42x |
| 2026-03-10 | 6.72x |
| 2026-03-09 | 6.86x |
| 2026-03-06 | 6.74x |
| 2026-03-05 | 6.90x |
| 2026-03-04 | 7.02x |
| 2026-03-03 | 7.06x |
| 2026-03-02 | 7.14x |
| 2026-02-27 | 6.96x |
| 2026-02-26 | 6.99x |
| 2026-02-25 | 6.69x |
| 2026-02-24 | 6.91x |
| 2026-02-23 | 8.02x |
| 2026-02-20 | 7.67x |
| 2026-02-19 | 7.55x |
| 2026-02-18 | 7.28x |
| 2026-02-17 | 7.22x |
| 2026-02-13 | 6.99x |
| 2026-02-12 | 7.28x |
| 2026-02-11 | 7.53x |
| 2026-02-10 | 7.59x |
| 2026-02-09 | 7.54x |
| 2026-02-06 | 7.44x |
| 2026-02-05 | 7.13x |
| 2026-02-04 | 7.31x |
| 2026-02-03 | 7.70x |
| 2026-02-02 | 7.59x |
| 2026-01-30 | 7.43x |
| 2026-01-29 | 7.56x |
| 2026-01-28 | 7.39x |
| 2026-01-27 | 7.85x |
| 2026-01-26 | 7.82x |
| 2026-01-23 | 7.87x |
| 2026-01-22 | 8.18x |
| 2026-01-21 | 8.20x |
| 2026-01-20 | 8.17x |
| 2026-01-16 | 8.20x |
| 2026-01-15 | 8.49x |
| 2026-01-14 | 8.67x |
| 2026-01-13 | 8.73x |
| 2026-01-12 | 8.71x |
| 2026-01-09 | 8.86x |
| 2026-01-08 | 9.02x |
| 2026-01-07 | 9.00x |
| 2026-01-06 | 9.21x |
| 2026-01-05 | 9.20x |
| 2026-01-02 | 9.32x |
| 2025-12-31 | 9.45x |
| 2025-12-30 | 9.50x |
| 2025-12-29 | 9.46x |
| 2025-12-26 | 9.44x |
| 2025-12-24 | 9.52x |
| 2025-12-23 | 9.48x |
| 2025-12-22 | 9.46x |
| 2025-12-19 | 9.39x |
| 2025-12-18 | 8.93x |
| 2025-12-17 | 8.97x |
| 2025-12-16 | 9.03x |
| 2025-12-15 | 9.28x |
| 2025-12-12 | 9.39x |
| 2025-12-11 | 9.43x |
| 2025-12-10 | 9.38x |
| 2025-12-09 | 9.18x |
| 2025-12-08 | 9.49x |
| 2025-12-05 | 9.43x |
| 2025-12-04 | 9.44x |
| 2025-12-03 | 9.45x |
| 2025-12-02 | 9.16x |
| 2025-12-01 | 9.22x |
| 2025-11-28 | 9.22x |
| 2025-11-26 | 9.29x |
| 2025-11-25 | 9.10x |
| 2025-11-24 | 9.47x |
| 2025-11-21 | 9.19x |
| 2025-11-20 | 8.88x |
| 2025-11-19 | 8.89x |
| 2025-11-18 | 8.88x |
| 2025-11-17 | 8.55x |
| 2025-11-14 | 8.40x |
| 2025-11-13 | 8.36x |
| 2025-11-12 | 8.62x |
| 2025-11-11 | 8.72x |
| 2025-11-10 | 8.39x |
| 2025-11-07 | 7.86x |
| 2025-11-06 | 7.84x |
| 2025-11-05 | 7.85x |
| 2025-11-04 | 10.17x |
| 2025-11-03 | 9.92x |
| 2025-10-31 | 9.78x |
| 2025-10-30 | 9.80x |
| 2025-10-29 | 9.60x |
| 2025-10-28 | 9.60x |
| 2025-10-27 | 9.69x |
| 2025-10-24 | 9.39x |
| 2025-10-23 | 9.71x |
| 2025-10-22 | 9.77x |
| 2025-10-21 | 10.07x |
| 2025-10-20 | 10.12x |
| 2025-10-17 | 10.37x |
| 2025-10-16 | 10.66x |
| 2025-10-15 | 10.66x |
| 2025-10-14 | 9.93x |
| 2025-10-13 | 10.00x |
| 2025-10-10 | 9.97x |
| 2025-10-09 | 10.01x |
| 2025-10-08 | 9.92x |
| 2025-10-07 | 9.73x |
| 2025-10-06 | 9.63x |
| 2025-10-03 | 9.26x |
| 2025-10-02 | 8.34x |
| 2025-10-01 | 8.14x |
| 2025-09-30 | 8.44x |
| 2025-09-29 | 8.24x |
| 2025-09-26 | 7.99x |
| 2025-09-25 | 7.86x |
| 2025-09-24 | 7.84x |
| 2025-09-23 | 7.89x |
Showing the most recent 260 of 1,356 data points. The chart above shows the full history.
